Intellectual Property India Publishes Patent Application for 'Antibodies And Chimeric Antigen Receptors Specific For Delta-Like Ligand 3 (DLL3)' Filed by Juno Therapeutics, Inc.

MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517024171 A) filed by Juno Therapeutics, Inc., Seattle, on March 18, for 'antibodies and chimeric antigen receptors specific for delta-like ligand 3 (dll3).'

Inventor(s) include Belmont, Brian Joshua; Williams, Madeline; Balakrishnan, Ashwini; Bedi, Samriti; Toy, Dean Y.; Busch, Stephanie; Huelar, Tiffany; and Zhu, Dan.

The application for the patent was published on May 2, under issue no. 18/2025.

According to the abstract released by the Intellectual Property India: "Provided are Delta-like ligand 3 (DLL3) -binding molecules, in particular, to human antibodies specific for DLL3, including antibody fragments. Also provided are recombinant receptor...